Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 308 $ 935
Trade receivables 1,792 378
Inventories 1,704 536
Other current assets 123 601
Total current assets 3,927 2,450
Non-current assets:    
Investment in affiliated companies accounted for under equity method, net 658 745
Investment in other company 455 224
Property and equipment, net 2,596 1,999
Prepaid expenses 361 591
Goodwill 7,761
Intangible assets 1,500
Total non-current assets 13,331 3,559
Total assets 17,258 6,009
Current liabilities:    
Receivables financing facility, net 1,306
Loans, net 2,756 1,672
Accounts payable 1,087 1,640
Deferred revenues 13 844
Other current liabilities 3,941 2,316
Liability for minimum royalties 296 291
Total current liabilities 8,093 8,069
Non-current liabilities:    
Convertible bridge loans, net 15,560 5,965
Derivative warrants liability, net 7 301
Fair value of bifurcated convertible feature of convertible bridge loans 2,077 2,500
Deferred taxes 315
Liability for minimum royalties 205 185
Total non-current liabilities 18,164 8,951
Shareholders’ deficit:    
Ordinary Shares of NIS 0.01 par value each: Authorized: 1,000,000,000 shares at June 30, 2021 and December 31, 2020; Issued and outstanding: 607,760,492 shares and 376,335,802 shares at June 30, 2021 and December 31, 2020, respectively 1,765 1,059
Additional paid-in capital 50,684 35,211
Accumulated deficit (61,448) (47,281)
Total shareholders’ deficit (8,999) (11,011)
Total liabilities and shareholders’ deficit $ 17,258 $ 6,009